Drug Shortage Report for ESOMEPRAZOLE

Last updated on 2021-09-22 History
Report ID 114022
Drug Identification Number 02394839
Brand name ESOMEPRAZOLE
Common or Proper name ESOMEPRAZOLE
Company Name PRO DOC LIMITEE
Market Status MARKETED
Active Ingredient(s) ESOMEPRAZOLE
Strength(s) 20MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 30
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-05-04
Estimated end date 2021-09-23
Actual end date 2021-09-21
Shortage status Resolved
Updated date 2021-09-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2925 BOULEVARD INDUSTRIEL
LAVAL, QUEBEC
CANADA H7L 3W9
Company contact information 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v26 2021-09-22 English Compare
v25 2021-09-21 French Compare
v24 2021-09-21 English Compare
v23 2021-09-20 French Compare
v22 2021-09-20 English Compare
v21 2021-09-15 French Compare
v20 2021-09-15 English Compare
v19 2021-09-13 French Compare
v18 2021-09-13 English Compare
v17 2021-08-04 French Compare
v16 2021-08-04 English Compare
v15 2021-07-13 French Compare
v14 2021-07-13 English Compare
v13 2021-03-02 French Compare
v12 2021-03-02 English Compare
v11 2021-01-13 French Compare
v10 2021-01-13 English Compare
v9 2020-11-30 French Compare
v8 2020-11-30 English Compare
v7 2020-10-21 French Compare

Showing 1 to 20 of 26